Microglia, the resident immune cells of the central nervous system (CNS), are activated by various stimuli. Resting microglia are the basis of normal neurogenesis, while activated microglia may inhibit neurogenesis through the production of pro-inflammatory mediators and cytokines. Recent research suggests that microglia are activated by irradiation. This may play a role in radiation-induced brain injury (RIBI). DNA double-strand breaks (DSBs), the most deleterious form of DNA damage after ionizing radiation, may rapidly trigger the activation of the NF-κB pathway via p53-induced protein leading to the release of pro-inflammatory mediators and cytokines. Thus, a negative regulator of the NF-κB pathway that inhibits radiation-induced microglia activation could be used to treat RIBI. Corilagin, a member of the tannin family, inhibits NF-κB pathway activation. In the present study, we examined the inhibitory effects of corilagin on radiation-induced microglia activation using a variety of techniques. Our data suggest that corilagin inhibits radiationinduced microglia activation via suppression of the NF-κB pathway and the compound is a potential treatment for RIBI.
Introduction
Microglial cells are the resident immune cells of the central nervous system (CNS) parenchyma and play a critical role in the development of the inflammatory response within the brain. Microglia cells react to a variety of stimuli, including lipopolysaccharides (LPS), interferon-Á, and ß-amyloid. It was reported recently that microglia are activated post-irradiation (1) . Upon activation in vitro, microglia produce a variety of pro-inflammatory mediators and cytokines, such as IL-1ß, IL-6, and TNF-·, reactive oxygen, nitric oxide (NO), and prostaglandin E (PGE 2 ), which are thought to be responsible for inflammation-related diseases, including radiation-induced brain injury (RIBI), trauma, ischemia, Alzheimer's disease, and neural death (2) . Brain irradiation leads to a marked increase in microglia activation and release of pro-inflammatory cytokines associated with inhibitory of neurogenesis in hippocampus in vivo (3, 4) . Small molecule inhibitors of these proinflammatory mediators and cytokines are needed for treatment of RIBI and other diseases.
DNA double-strand breaks (DSBs) are the most deleterious form of DNA damage and numerous in vitro studies have analyzed the DSB repair system that is activated after exposure to ionizing radiation. DSBs rapidly trigger the activation of NF-κB pathway via NEMO (5, 6) . The death-domain protein PIDD was originally identified as an early p53-inducible gene and is implicated in p53-induced apoptosis (5) . PIDD is a mediator of the DNA-damage-activated stress response and is involved in genotoxic stress-induced NF-κB activation (6, 7) . PIDD expression enhances genotoxic-stress-induced NF-κB activation through augmented sumoylation and ubiquitination of NEMO (7) .
Corilagin (ß-1-O-galloyl-3,6-(R)-hexahydroxydiphenoyl-D-glucose) is a member of the tannin family and has been isolated from medicinal plants, such as the Phyllanthus species (8) . The molecular formula of corilagin is C 27 H 22 O 18 (9) . The structure of corilagin is given in Fig. 1A . Corilagin has antioxidative, -atherogenic, and -hypertensive effects in various models (8) (9) (10) (11) . A preliminary in vitro study suggested that corilagin has anti-inflammatory activity (12) . The activation of microglia and release of pro-inflammatory cytokines postirradiation are regarded as the key effectors of RIBI. The purpose of this study was to investigate whether corilagin administration inhibits microglia activation by blocking NF-κB pathway activation.
Materials and methods
Materials. Corilagin standard substance (purity 99%) was obtained from the China National Institute for the Control of Pharmaceutical and Biological Products. RPMI-1640 was from Gibco (Grand Island, NY, USA). 3-(4,5-dimethyl-2thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) was obtained from Sigma (St. Louis, MO, USA). The anti-Iba-1 rabbit antibody was from Wako Chemical (Osaka, Japan). NEMO and IκB-· primary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The anti-Á-H2AX mouse monoclonal antibody was purchased from Abcam (Cambridge, MA, USA). AlexaFluor-488 conjugated Corilagin inhibits the double strand break-triggered NF-κ κB pathway in irradiated microglial cells goat anti-mouse, donkey anti-goat secondary antibody, and AlexaFluor-568 conjugated goat anti-rabbit secondary antibody were purchased from Invitrogen (Carlsbad, CA, USA MTT assay. The cytotoxicity of corilagin was determined using the MTT assay. Cells (1x10 5 /well) were plated in 100 μl of medium/well in 96-well plates. After incubation overnight, the medium from each well was discarded and replaced with fresh medium containing corilagin at concentrations ranging from 1.0 to 250.0 μg/ml. BV-2 cells not treated with corilagin were used as controls. After treatment with corilagin for 24 h, 20 μl of 5 mg/ml MTT (pH 4.7) was added to each well. After 4 h, the supernatant was removed, 100 μl/well DMSO was added, and samples were shaken for 15 min. The optical density (OD) at 570 nm was measured with a microplate reader (Bio-Rad, Richmond, CA, USA) using wells without cells as blanks. All experiments were performed in triplicate.
Irradiation. Cells were irradiated using a 137 Cs irradiator (Siemens, Germany). The irradiation parameters were as follows: beam energy, 6 MV photons; dose-rate, 2.0 Gy/min; source skin distance (SSD), 99 cm; irradiation size, 30x30 cm 2 . Sham-exposed cells were used as controls. All irradiations were performed at room temperature.
Expression of ionized calcium binding (Iba)-1 in BV-2 cells.
After BV-2 cells were irradiated for 0.5, 3, 6, 12, 24, or 48 h in the presence or absence of 5.0 μg/ml corilagin, sections were incubated with anti-Iba-1 antibody (1:200) followed by AlexaFluor-568 conjugated secondary antibodies (1:200). Expression levels were determined using confocal microscopy for comparison to control, untreated cells.
Analysis of IL-1ß, TNF-· and IL-6 in supernatant. After irradiation in presence or absence of corilagin, BV-2 cell supernatants were assayed for IL-1ß, TNF-·, and IL-6 by ELISA as per the manufacturer's instructions. The absorbance at 450 nm was determined using a microplate reader.
Analysis of NO.
Levels of the NO derivative nitrite were determined using the Griess reaction. The nitrite detection assay was preformed according to instructions provided by the manufacturer. The samples were assayed in triplicate and a standard curve using NaNO 2 was generated for each experiment for quantification. Briefly, 100 μl of medium or NaNO 2 standard was mixed with 100 μl of Griess reagent in a 96-well plate. After 15 min, OD was read in a microplate reader at 540 nm. Western blot analysis. Cells were seeded in six-well plates and pre-treated with or without 5.0 μg/ml corilagin before 32-Gy irradiation for 6 h. Cells were then lysed. To determine the levels of NF-κB, nuclear extracts were prepared from irradiated cells (13) and then resolved on 15% sodium dodecyl sulfate polyacrylamide gels (SDS-PAGE). Proteins were transferred to a nitrocellulose membrane for 12-16 h at 30 V, blocked in 5% nonfat skim milk in Tris-buffered saline with 0.1% Tween 20 (TBST) for 1 h at room temperature and then incubated overnight with primary antibody (1:200) diluted in 2% BSA in TBST at 4˚C. The following day, proteins were visualized using the ECL detection system after incubation with the respective HRP-conjugated secondary antibody (1:1.000).
Complexes of the primary and secondary antibodies were visualized by using a chemiluminescent substrate kit and exposed to medical X-ray film. The intensity of the blots was quantified with a gel-image analyzer (JS380; Peiqing Science and Technology, Shanghai, China).
Immunofluorescence staining and confocal microscopy. BV-2 cells were plated onto polylysine-coated cover glass and treated with irradiation. Samples were fixed in methanol, permeabilized in acetone, and then blocked in 1% goat serum. Anti-NEMO, IκB-· primary antibody (1:200), or Á-H2AX primary antibody (1:800) was applied after blocking overnight at 4˚C, followed by the AlexaFluor-488 conjugated goat anti-rabbit and donkey anti-goat secondary antibodies (1:200) . Samples were mounted in Vectashield mounting medium with 4,6-diamidino-2-phenylindole. Cells were observed using a fluorescence microscope (Olympus, Tokyo, Japan) for green, red, and blue fluorescence, then observed using confocal laser microscopy (FV500, Olympus, Tokyo, Japan) at x400 and x1,000 magnification.
Statistical analysis. Each test was repeated three times. Data are presented as mean ±SD. Comparisons of the measurement data among multiple groups were performed with one-way ANOVA test. Rates were compared with Chi-square test. Results were considered statistically significant when p<0.05. The statistical analysis was performed with SPSS12.0 software.
Results

Effects of corilagin on in BV-2 cells.
Iba-1 is upregulated during the activation of microglial cells. Under normal conditions, Iba-1 was expressed at low levels in BV-2 cells (Fig. 1B) . The expression of Iba-1 was significantly increased post-irradiation with 32 Gy, demonstrating that microglia cells are activated by irradiation. The expression of Iba-1 was inhibited by pre-treatment with corilagin, which indicated that the activation of microglial cells was repressed. As shown in Fig. 2A , the concentrations of corilagin used here (1.0 to 250.0 μg/ml) had no effect on the viability of BV-2 cells. We investigated corilagin's effect on the expression of pro-inflammatory cytokines and mediators, including IL-1ß, TNF-·, IL-6, PIDD, and COX-2. BV-2 microglia cells were incubated with corilagin and then cells were irradiated (32 Gy). Expression of pro-inflammatory cytokines, with the exception of IL-6, was significantly decreased in cells pre-treated with corilagin compared to untreated control cells as determined by RT-PCR (Fig. 2B) . IL-1ß, TNF-·, and IL-6 protein levels in cell supernatant were increased post-irradiation ( Fig. 2C-E) . Corilagin pre-treatment significantly inhibited the production of these cytokines (p<0.05). As shown in Fig. 2F , after 32-Gy irradiation, secretion of NO was significantly decreased by treatment with corilagin in comparison to untreated cells (p<0.05).
Corilagin inhibits signaling through the NF-κB pathway.
Expression of p65 protein increased significantly in the nucleus after irradiation with 32 Gy at every time point (data not shown). When pre-treated with 5.0 μg/ml corilagin, the level of p65 protein in the nucleus was significantly reduced (Fig. 3 ) at 6 h post-irradiation. This implies that corilagin inhibited the radiation-induced NF-κB pathway activation.
Effect of corilagin on the expression of NEMO and IκB-·.
The DSB repair kinetics in BV-2 cells was evaluated by analysing Á-H2AX foci at indicated time points (0.5-48 h) post irradiation. Non-irradiated microglia were predominantly negative for Á-H2AX; a homogeneous pattern of discrete nuclear Á-H2AX foci was observed at 0.5 h post-irradiation ( Fig. 4A ). BV-2 cells displayed only low levels of residual damage, as indicated by the number of foci at 48 h postirradiation.
Immunofluorescence analysis (Fig. 4B) showed that in untreated, non-irradiated BV-2 cells, IκB-· was expressed indicating that NF-κB was inactivated. After 32-Gy irradiation, the expression of IκB-· was inhibited, which indicated that NF-κB was activated and IκB-· was dissociated and degraded. After pre-treatment with 5.0 μg/ml corilagin for 12 h, the levels of IκB-· expression were higher than in the non-irradiated cells. Fig. 4C shows the immunofluorescence staining of NEMO in the BV-2 cells analysed 12 h after 32-Gy irradiation. Cells that were not irradiated were almost completely negative for NEMO. The degree of NEMO staining clearly increased after irradiation. The expression of NEMO was inhibited when cells were pre-treated with 5.0 μg/ml corilagin. This indicated that corilagin inhibited NEMO activation, resulting in the observed inhibition of p65 expression.
Discussion
Microglia play a major role in pathological events leading to inflammatory-related diseases such as radiation-induced brain injury, Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Recent studies indicate that irradiation induces microglia activation in vitro, which leads to a marked increase level of pro-inflammatory cytokines (1, 14, 15) . Radiation-induced microglia activation may play a role in RIBI since pro-inflammatory cytokines inhibit neurogenesis. In our study, we evaluated the effect of the tannin family member corilagin on activated microglial cells.
Iba-1 is highly and specifically expressed in monocytic cell lines and cultured microglia. Iba1 protein levels are upregulated in activated microglia (6) . Our study showed that Iba-1 expression was upregulated upon irradiation. Pretreatment with corilagin attenuated this upregulation of Iba-1. COX-2 and NO are the key mediators and regulators of inflammation. COX-2 and NO are induced by inflammatory stimuli (16, 17) . Corilagin treatment significantly reduced the levels of these mediators in irradiated BV-2 cells. These data indicated that corilagin inhibited activation of microglial cells.
DSBs are considered the most deleterious DNA lesions. If left unrepaired, this damage severely threatens not only the integrity of the genome but also the survival of the organism. Within minutes following the induction of DSBs, the histone H2AX is phosphorylated. The phosphorylated form, called Á-H2AX, recruits DNA damage response factors to sites of DNA damage (18, 19) . Using a fluorescent antibody specific for the Á-H2AX, discrete nuclear foci can be visualized at sites of DSBs. Numbers of Á-H2AX foci are correlated with the extent of radiation-induced DSBs in vitro and in vivo (20, 21) . Irradiation induced significant DNA damage in B7-2 cells.
NF-κB is activated in response to DSBs (22) (23) (24) . The NF-κB signaling pathway mediates a variety of important cellular functions by regulating immune and inflammatory responses. In unstimulated cells, NF-κB is in the form of a heterodimer of p65/p50 and binds to the inhibitor protein, IκB. After stimulation, p65/p50 is released from the IκB-·, IκB-· is degraded, and p65 translocates into the nucleus to regulate gene transcription. Central to the activation of NF-κB by stimuli is the IκB kinase (IKK) complex that is composed of IKK·/1 and IKKß/2 and NF-κB essential modulator (NEMO/IKKÁ). The death-domain protein PIDD, originally Non-irradiated normal cells were predominantly negative for Á-H2AX, whereas a homogeneous pattern of discrete nuclear Á-H2AX foci was observed after 0.5 h in irradiated cells. DNA repair is rapid in BV-2 cells and only low levels of residual damage were observed at 48 h post-irradiation. Original magnification x1,000. B. Confocal images of IκB-· (green) immunofluorescence staining in BV-2 cells analyzed at 12 h after irradiation with 32 Gy. DNA was counterstained with DAPI (blue). Shown are control cells, irradiated cells (RT), and cells treated with 5.0 μg/ml corilagin prior to irradiation (RT+Coril). Original magnification x1,000. C. Confocal images of NEMO (green) immunofluorescence staining in BV-2 cells analyzed at 12 h after irradiation with 32 Gy. DNA was counterstained with DAPI (blue). Original magnification x1,000.
identified as an early p53-inducible gene that is implicated in p53-induced apoptosis (5) , is a mediator of the DNAdamage-activated stress response (6, 7) . PIDD expression enhances genotoxic-stress-induced NF-κB activation through augmented sumoylation and ubiquitination of NEMO (7) . Pre-treatment with corilagin prior to irradiation increased IκB-· levels and inhibited expression of NEMO when compared to levels in untreated microglial cells.
Our studies demonstrated that corilagin exhibited antiinflammatory activity in irradiated B7-2 cells by suppressing the release of pro-inflammatory cytokines and mediators. Corilagin suppressed the transcription of pro-inflammatory cytokine genes through effects on the DSB-triggered NF-κB signaling pathway. Microglia cells play a critical role in the development of an inflammatory response within the brain. Microglia cells are activated in response to ionizing radiation, resulting in induction of pro-inflammatory cytokines. Pretreatment of the microglia cells with corilagin inhibited proinflammatory responses. This compound may be used for the treatment of RIBI.
